China 'No' For Celgene's Paclitaxel A Major Blow To BeiGene

Inspections Report 20% GMP Non-Compliance

 
• By Brian Yang
  
production line
CHINA SUSPENDS CELGENE'S PACLITAXEL DUE TO GMP ISSUES • Source: Shutterstock

More from Manufacturing

More from Business